Broad-spectrum nanoparticle flu vaccine shows promise in mice

A nanoparticle vaccine developed at the University of Michigan targets a slowly mutating influenza protein, providing mice with protection against three different flu strains. This approach could reduce reliance on annual strain predictions and improve vaccine effectiveness, which currently ranges from 30% to 60%. The findings were presented at the American Chemical Society's fall 2026 conference.